In Vitro Susceptibility of Chromoblastomycosis and Phaeohyphomycosis Agents to Antifungal Drugs

Med Mycol. 1999 Dec;37(6):405-9. doi: 10.1046/j.1365-280x.1999.00245.x.

Abstract

The in vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs was appraised using the reference macrodilution method proposed by the National Committee for Clinical Laboratory Standards (NCCLS) for yeasts modified for filamentous fungi. The antifungal drugs amphotericin B, 5-fluorocytosine, itraconazole and fluconazole were tested against one environmental and 18 clinical isolates. This work amended the macrodilution methods proposed by NCCLS and suggests that a conidial suspension free of hyphae leads to a more reliable assay and provides for better reproducibility. The macrodilution method was performed with 10(4) conidia ml-1. The MIC values ranged from 1.0 to 16.0 micrograms ml-1 for amphotericin B and 3.12 to 25.0 micrograms ml-1 for 5-fluorocytosine. A MIC range of 0.06 to 1.95 micrograms ml-1 was determined for itraconazole while 2.0 to 64.0 micrograms ml-1 was detected for fluconazole.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / pharmacology*
  • Chromoblastomycosis / microbiology*
  • Fluconazole / pharmacology
  • Flucytosine / pharmacology
  • Fungi / drug effects*
  • Humans
  • Itraconazole / pharmacology
  • Microbial Sensitivity Tests

Substances

  • Antifungal Agents
  • Itraconazole
  • Fluconazole
  • Flucytosine